Sophie Hallez

Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein?based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia

Sophie Hallez, Philippe Simon, Fr�d�ric Maudoux et al. · Cancer Immunology Immunotherapy · 2004 · 110 citations · Full text

Medicine, Immunology, Oncology +17

Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography

Carine Asselin‐Paturel, Nathalie Lassau, Guinebretière Jm et al. · Gene Therapy · 1999 · 107 citations

Life Sciences, Immunology, Oncology +16

Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16

Christian Desaintes, Sophie Hallez, Patrick Van Alphen et al. · Journal of Virology · 1992 · 79 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Interleukin‐12‐secreting human papillomavirus type 16–transformed cells provide a potent cancer vaccine that generates E7‐directed immunity

Sophie Hallez, Odile Detremmerie, Christina Giannouli et al. · International Journal of Cancer · 1999 · 48 citations

Medicine, Immunology, Oncology +17

HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes

Hélène Le Buanec, R. D'Anna, A Lachgar et al. · Biomedicine & Pharmacotherapy · 1999 · 41 citations

Life Sciences, Molecular Biology, Oncology +17